Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Anthem Biosciences Limited (ANTHEM) Price & Analysis

ANTHEM Stock Chart & Stats

₹828.45-₹2.55(-0.31%)
At close: 4:00 PM EDT
INR 800INR 850INR 900INR 9503 Aug17 Aug31 Aug15 Sep28 Sep12 Oct26 Oct
Day’s Range
INR 825.75 - INR 845.35
52-Week Range
INR 579.45 - INR 977.00
Previous Close
INR 831.00
Volume
527.90K
Average Volume (3M)
189.04K
Market Cap
INR 466.85B
Enterprise Value
INR 364.00B
Total Cash (Recent Filing)
INR 11.00B
Total Debt (Recent Filing)
INR 1.10B
Price to Earnings (P/E)
80.9
Beta
0.80
Next Earnings
Nov 03, 2026
EPS Estimate
3.5
Next Dividend Ex-Date
N/A
Dividend Yield
0.24%

Bulls Say, Bears Say

Bulls Say

Strong Revenue And Profit Growth

Rapid revenue growth combined with higher net income indicates strong customer demand and operating execution. If supported by recurring contract research and manufacturing programs, this can expand the company’s earnings base over the next several quarters.

Low Leverage And Growing Equity

Debt reduction and equity growth strengthen financial resilience and reduce dependence on external funding. A conservative balance sheet gives Anthem greater flexibility to invest in capacity, technology, and development capabilities as customer demand evolves.

Improved Cash Generation

The sharp improvement in operating and free cash flow suggests stronger internal funding capacity. Sustained cash generation could support facility expansion, process development, and working-capital needs without materially increasing leverage.

Bears Say

Uncertain Sustainability Of Exceptional Growth

Growth at this unusually high rate may reflect an elevated comparison effect, project timing, or temporary mix changes. Without additional periods of results, investors cannot yet determine whether the expansion represents a durable acceleration in recurring demand.

Limited Margin And Cash Flow History

Incomplete current-year margin information makes it difficult to assess whether growth is translating into sustainable profitability across services and manufacturing. A limited track record for the cash-flow step-up also reduces confidence in long-term conversion.

Limited Liquidity And Debt-Maturity Visibility

Although reported leverage is low, missing liquidity and maturity information leaves uncertainty around near-term financial flexibility. This matters for a business that may require continuing capital investment in facilities, equipment, and development infrastructure.

Anthem Biosciences Limited News

ANTHEM FAQ

What was Anthem Biosciences Limited’s price range in the past 12 months?
Anthem Biosciences Limited lowest stock price was ₹579.45 and its highest was ₹977.00 in the past 12 months.
What is Anthem Biosciences Limited’s market cap?
Anthem Biosciences Limited’s market cap is ₹466.85B.
When is Anthem Biosciences Limited’s upcoming earnings report date?
Anthem Biosciences Limited’s upcoming earnings report date is Nov 03, 2026 which is in 2 days.
How were Anthem Biosciences Limited’s earnings last quarter?
Anthem Biosciences Limited released its earnings results on Jul 21, 2026. The company reported ₹2.1 earnings per share for the quarter.
Is Anthem Biosciences Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Anthem Biosciences Limited pay dividends?
Anthem Biosciences Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.24%. See more information on Anthem Biosciences Limited dividends here
What is Anthem Biosciences Limited’s EPS estimate?
Anthem Biosciences Limited’s EPS estimate is 3.50.
How many shares outstanding does Anthem Biosciences Limited have?
Anthem Biosciences Limited has 563,528,000 shares outstanding.
What happened to Anthem Biosciences Limited’s price movement after its last earnings report?
Anthem Biosciences Limited reported an EPS of ₹2.1 in its last earnings report. Following the earnings report the stock price went up 0.019%.
Which hedge fund is a major shareholder of Anthem Biosciences Limited?
Currently, no hedge funds are holding shares in IN:ANTHEM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology